Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
International Journal of Dermatology · 2026-12 · 65 (12) · 2581-2583
DOI: 10.1111/ijd.70460 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 02.05.2026. Verfasst von Kateryna Karpoff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Kateryna Karpoff, Mark Lebwohl
Zitieren
APA
Karpoff, K., Patel, A., Erfe, G., Guttman-Yassky, E., & Lebwohl, M. (2026). Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens. International Journal of Dermatology, 65(12), 2581-2583. https://doi.org/10.1111/ijd.70460
Vancouver
Karpoff K, Patel A, Erfe G, Guttman-Yassky E, Lebwohl M. Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens. International Journal of Dermatology. 2026;65(12):2581-2583. doi:10.1111/ijd.70460
BibTeX
@article{Karpoff2026,
author = {Karpoff, Kateryna and Patel, Anya and Erfe, Georgina and Guttman-Yassky, Emma and Lebwohl, Mark},
title = {Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {12},
pages = {2581--2583},
doi = {10.1111/ijd.70460}
}
EUVIMED